Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.06 USD | +2.64% | +1.01% | +187.96% |
May. 08 | Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Treatment of Myotonic Dystrophy Type 1 | MT |
May. 08 | Avidity's Lead Program Gets FDA Breakthrough Designation | DJ |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- MarketScreener Editorial Features